Discovery and characterization of naturally occurring covalent inhibitors of SARS-CoV-2 Mpro from the anti-viral herb Ephedra
-
HU Qing,
-
ZHANG Yiwen,
-
CHEN Pengcheng,
-
ZHANG Yani,
-
ZHU Guanghao,
-
LIU Wei,
-
WANG Chaoran,
-
ZHENG Shuilian,
-
SHEN Nonger,
-
WANG Haonan,
-
HUANG Ping,
-
GE Guangbo
-
Abstract
The Chinese herb Ephedra (also termed Mahuang) has been widely used for the prevention and treatment of coronavirus-caused diseases, including coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Ephedra is a key material for preparing some famous anti-viral Chinese medicines that have been used for combating COVID-19, but its anti-SARS-CoV-2 substances and underlying mechanisms have not been fully revealed. The main protease (Mpro) is a highly conserved protease responsible for proteolytic processing during the viral life cycle, making it a key target for anti-coronavirus therapy development. This study aimed to find the naturally occurring covalent inhibitors of SARS-CoV-2 Mpro from the anti-viral herb Ephedra, as well as to investigate their covalent binding sites and anti-SARS-CoV-2 Mpro mechanisms. The results demonstrated that the Ephedra non-alkaloid fraction (ENA) showed potent anti-SARS-CoV-2 Mpro effect, while the alkaloid fraction of Ephedra did not inhibit Mpro. The chemical constituents in ENA were then identified and the anti-SARS-CoV-2 Mpro effects of the major constituents in ENA were evaluated. Among all tested constituents, herbacetin and gallic acid in ENA time- and dose-dependently inhibited SARS-CoV-2 Mpro, while their combination exhibited significant synergistic effect on this key enzyme. Moreover, a series of techniques, such as inhibition kinetic assays, chemoproteomic methods, and molecular dynamics simulations, were employed to further elucidate the synergistic anti-Mpro mechanisms of the combination of two identified natural Mpro inhibitors (herbacetin and gallic acid). Overall, this study deciphers the naturally occurring covalent inhibitors of SARS-CoV-2 Mpro from the anti-viral herb Ephedra and characterizes their anti-Mpro synergistic effect, which offers powerful evidence to support the anti-coronavirus effects of the Chinese herb Ephedra.
-
-